Veradermics, Incorporated (MANE)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	n/a
Net Income	-61,641
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MANE

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for pattern hair loss, a condition affecting approximately 50 million men and 30 million women in the United States.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 19
• Stock Exchange: NYSE
• Ticker Symbol: MANE
• Website: https://www.veradermics.com/

Financial Performance

Financial numbers in USD